医疗营养市场－全球产业规模、份额、趋势、机会和预测，按给药途径、应用、最终用户、地区和竞争细分，2020-2030 年预测

2024 年全球医疗营养市场价值为 622 亿美元，预计在预测期内将实现令人印象深刻的成长，到 2030 年的复合年增长率为 7.72%。全球医疗营养市场涵盖各种专门的营养产品和补充剂，旨在解决特定的医疗状况和营养需求。这些产品适用于因各种健康问题（包括营养不良、慢性疾病、胃肠道疾病等）而需要客製化营养解决方案的个人。例如，根据世界卫生组织 2022 年的数据，全球约有 1.49 亿 5 岁以下儿童发育迟缓，4,500 万名儿童被认为是体重减轻。南亚次区域五岁以下儿童营养不良问题严重。此外，联合国报告称，亚洲营养不良人口从 2019 年的 3.613 亿增加到 2020 年的 4.18 亿，营养不良发生率从 7.9% 上升到 9.0%。医学营养是指专门使用营养素、客製化饮食和治疗性食品配方来管理特定的健康状况、支持康復和改善整体健康。它是医疗保健的重要组成部分，针对营养不良、慢性疾病、代谢紊乱以及手术或受伤后的恢復等情况。医疗营养包括口服补充剂、肠内餵食（管饲）和常规饮食不足时的肠外营养（静脉餵食）。它是在医学监督下设计的，旨在解决个人营养缺乏问题，优化健康结果，并预防併发症。医学营养在提高各种疾病患者的生活品质方面发挥关键作用。

主要市场驱动因素

健康意识不断增强

主要市场挑战

严格的品质保证

主要市场趋势

个人化营养

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球医疗营养市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依给药途径（口服、肠内、肠外）
  • 依应用（营养不良、代谢失调、胃肠道疾病、癌症、神经系统疾病、其他）
  • 按最终使用者（儿童、成人）
  • 按地区
  • 按公司分类（2024）
• 产品市场图
  • 依给药途径
  • 按应用
  • 按最终用户
  • 按地区

第 6 章：北美医疗营养市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 加拿大
  • 墨西哥

第七章：欧洲医疗营养市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 英国
  • 法国
  • 义大利
  • 西班牙

第八章：亚太医疗营养市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 日本
  • 印度
  • 澳洲
  • 韩国

第 9 章：南美洲医疗营养市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲医疗营养市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 科威特

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 合併与收购
• 产品发布

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Abbott Nutrition Ltd
• Nestle Health Science SA
• Baxter Healthcare Corp
• B Braun SE
• Danone SA
• Perrigo Co PLC
• Fresenius Kabi AG
• AYMES Nutrition
• Reckitt Benckiser Group PLC
• Ajinomoto Cambrooke Inc.

第 15 章：策略建议

第16章调查会社について・免责事项

Global Medical Nutrition Market was valued at USD 62.20 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.72% through 2030. The global medical nutrition market encompasses a diverse range of specialized nutritional products and supplements designed to address specific medical conditions and nutritional needs. These products are utilized by individuals who require tailored nutrition solutions due to various health issues, including malnutrition, chronic diseases, gastrointestinal disorders, and more. For instance, According to the World Health Organization in 2022, approximately 149 million children under the age of 5 were estimated to be stunted, while 45 million were considered wasted globally. The South Asia sub-region bears a significant burden of malnutrition among children under 5 years old. Also, the UN reports that Asia's undernourished population rose from 361.3 million in 2019 to 418.0 million in 2020, with the prevalence of undernourishment increasing from 7.9% to 9.0%. Medical nutrition refers to the specialized use of nutrients, tailored diets, and therapeutic food formulations to manage specific health conditions, support recovery, and improve overall well-being. It is an essential component of healthcare, targeting conditions such as malnutrition, chronic illnesses, metabolic disorders, and recovery from surgeries or injuries. Medical nutrition includes oral supplements, enteral feeding (tube feeding), and parenteral nutrition (intravenous feeding) when regular diets are insufficient. Designed under medical supervision, it addresses individual nutritional deficiencies, optimizes health outcomes, and prevents complications. Medical nutrition plays a pivotal role in enhancing the quality of life for patients across various medical conditions.

Key Market Drivers

Rising Health Awareness

In recent years, a notable shift has occurred in how people perceive health and wellness. There is an increasing awareness of the profound connection between nutrition and well-being, which has significantly contributed to the growth of the global medical nutrition market. This heightened health consciousness is driving individuals to seek specialized nutrition solutions, making the medical nutrition market a dynamic and rapidly expanding industry. For instance, The World Health Organization (WHO) reports that the global population aged 60 and over is projected to grow substantially, increasing from approximately 1 billion in 2020 to about 1.4 billion by 2030. Furthermore, it is expected to nearly double by 2050, reaching around 2.1 billion.

Rising health awareness has prompted a paradigm shift from reactive healthcare to proactive health management. Individuals are increasingly taking charge of their well-being by adopting healthier lifestyles and actively seeking ways to prevent health issues. Medical nutrition plays a crucial role in this shift, offering a means to prevent and manage health conditions through tailored dietary interventions.

Key Market Challenges

Stringent Quality Assurance

Quality assurance is paramount in the medical nutrition market. Ensuring the safety and efficacy of these products is a complex process, with strict standards set by regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA). Adherence to these standards is essential to maintain consumer trust, which can be a challenge for smaller manufacturers and new entrants in the market.

Key Market Trends

Personalized Nutrition

Personalization is a dominant trend across the food and nutrition industry, and medical nutrition is no exception. The future of medical nutrition is increasingly individualized, with tailored solutions that account for a person's unique health status, dietary preferences, and genetics. This trend is enabled by the growing understanding of nutrigenomics, which explores how an individual's genes interact with their diet, allowing for precision nutrition recommendations.

Key Market Players

• Abbott Nutrition Ltd
• Nestle Health Science SA
• Baxter Healthcare Corp
• B Braun SE
• Danone SA
• Perrigo Co PLC
• Fresenius Kabi AG
• AYMES Nutrition
• Reckitt Benckiser Group PLC
• Ajinomoto Cambrooke Inc.

Report Scope:

In this report, the Global Medical Nutrition Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Medical Nutrition Market, By Route of Administration:

• Oral and Enteral
• Parenteral

Medical Nutrition Market, By Application:

• Malnutrition
• Metabolic Disorders
• Gastrointestinal Diseases
• Cancer
• Neurological Diseases
• Others

Medical Nutrition Market, By End User:

• Pediatric
• Adult

Medical Nutrition Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Medical Nutrition Market.

Available Customizations:

Global Medical Nutrition market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Medical Nutrition Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Route of Administration (Oral and Enteral, Parenteral)
  • 5.2.2. By Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Cancer, Neurological Diseases, Others)
  • 5.2.3. By End User (Pediatric, Adult)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Route of Administration
  • 5.3.2. By Application
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Medical Nutrition Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Route of Administration (Oral and Enteral, Parenteral)
  • 6.2.2. By Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Cancer, Neurological Diseases, Others)
  • 6.2.3. By End User (Pediatric, Adult)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Medical Nutrition Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Route of Administration
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Medical Nutrition Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Route of Administration
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Medical Nutrition Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Route of Administration
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Medical Nutrition Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Route of Administration (Oral and Enteral, Parenteral)
  • 7.2.2. By Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Cancer, Neurological Diseases, Others)
  • 7.2.3. By End User (Pediatric, Adult)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Medical Nutrition Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Route of Administration
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom Medical Nutrition Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Route of Administration
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. France Medical Nutrition Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Route of Administration
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Medical Nutrition Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Route of Administration
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Medical Nutrition Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Route of Administration
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Medical Nutrition Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Route of Administration (Oral and Enteral, Parenteral)
  • 8.2.2. By Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Cancer, Neurological Diseases, Others)
  • 8.2.3. By End User (Pediatric, Adult)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Medical Nutrition Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Route of Administration
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. Japan Medical Nutrition Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Route of Administration
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. India Medical Nutrition Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Route of Administration
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. Australia Medical Nutrition Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Route of Administration
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. South Korea Medical Nutrition Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Route of Administration
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Medical Nutrition Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Route of Administration (Oral and Enteral, Parenteral)
  • 9.2.2. By Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Cancer, Neurological Diseases, Others)
  • 9.2.3. By End User (Pediatric, Adult)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Medical Nutrition Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Route of Administration
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Medical Nutrition Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Route of Administration
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Medical Nutrition Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Route of Administration
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Medical Nutrition Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Route of Administration (Oral and Enteral, Parenteral)
  • 10.2.2. By Application (Malnutrition, Metabolic Disorders, Gastrointestinal Diseases, Cancer, Neurological Diseases, Others)
  • 10.2.3. By End User (Pediatric, Adult)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Medical Nutrition Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Route of Administration
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Medical Nutrition Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Route of Administration
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Medical Nutrition Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Route of Administration
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User
  • 10.3.4. Kuwait Medical Nutrition Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Route of Administration
      • 10.3.4.2.2. By Application
      • 10.3.4.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Abbott Nutrition Ltd
• 14.2. Nestle Health Science SA
• 14.3. Baxter Healthcare Corp
• 14.4. B Braun SE
• 14.5. Danone SA
• 14.6. Perrigo Co PLC
• 14.7. Fresenius Kabi AG
• 14.8. AYMES Nutrition
• 14.9. Reckitt Benckiser Group PLC
• 14.10. Ajinomoto Cambrooke Inc.

15. Strategic Recommendations

16. About Us & Disclaimer